D.E. Shaw & Co’s Ibere Pharmaceuticals IBER Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-150,000
| Closed | -$1.51M | – | 3826 |
|
|
2022
Q4 | $1.51M | Sell |
150,000
-125,008
| -45% | -$1.26M | ﹤0.01% | 2199 |
|
|
2022
Q3 | $2.73M | Buy |
275,008
+100
| +0% | +$991 | ﹤0.01% | 1930 |
|
|
2022
Q2 | $2.7M | Buy |
274,908
+101,946
| +59% | +$1M | ﹤0.01% | 2067 |
|
|
2022
Q1 | $1.7M | Sell |
172,962
-231,214
| -57% | -$2.27M | ﹤0.01% | 2541 |
|
|
2021
Q4 | $3.93M | Buy |
404,176
+242,637
| +150% | +$2.36M | ﹤0.01% | 1885 |
|
|
2021
Q3 | $1.57M | Buy |
161,539
+136,539
| +546% | +$1.32M | ﹤0.01% | 2241 |
|
|
2021
Q2 | $242K | Buy |
+25,000
| New | +$242K | ﹤0.01% | 3183 |
|